Asset Details
Do you wish to reserve the book?
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
Do you wish to request the book?
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects
2015
Overview
Although the efficacy of racemate ketamine, a rapid onset and sustained antidepressant, for patients with treatment-resistant depression was a serendipitous finding, clinical use of ketamine is limited, due to psychotomimetic side effects and abuse liability. Behavioral and side-effect evaluation tests were applied to compare the two stereoisomers of ketamine. To elucidate their potential therapeutic mechanisms, we examined the effects of these stereoisomers on brain-derived neurotrophic factor (BDNF)–TrkB signaling, and synaptogenesis in selected brain regions. In the social defeat stress and learned helplessness models of depression,
R
-ketamine showed a greater potency and longer-lasting antidepressant effect than
S
-ketamine (esketamine). Furthermore,
R
-ketamine induced a more potent beneficial effect on decreased dendritic spine density, BDNF–TrkB signaling and synaptogenesis in the prefrontal cortex (PFC), CA3 and dentate gyrus (DG) of the hippocampus from depressed mice compared with
S
-ketamine. However, neither stereoisomer affected these alterations in the nucleus accumbens of depressed mice. In behavioral tests for side effects,
S
-ketamine, but not
R
-ketamine, precipitated behavioral abnormalities, such as hyperlocomotion, prepulse inhibition deficits and rewarding effects. In addition, a single dose of
S
-ketamine, but not
R
-ketamine, caused a loss of parvalbumin (PV)-positive cells in the prelimbic region of the medial PFC and DG. These findings suggest that, unlike
S
-ketamine,
R
-ketamine can elicit a sustained antidepressant effect, mediated by increased BDNF–TrkB signaling and synaptogenesis in the PFC, DG and CA3.
R
-ketamine appears to be a potent, long-lasting and safe antidepressant, relative to
S
-ketamine, as
R
-ketamine appears to be free of psychotomimetic side effects and abuse liability.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
